PDF icon Download PDF
Semin Thromb Hemost 2011; 37(7): 730-736
DOI: 10.1055/s-0031-1297163
© Thieme Medical Publishers

Intraventricular Hemorrhage in Preterm Infants: Coagulation Perspectives

Amir A. Kuperman1 , 2 , Gili Kenet3 , 4 , Emmanuel Papadakis5 , Benjamin Brenner2 , 6
  • 1Pediatric Hematology Clinic, Thrombosis and Hemostasis Service, Institute of Hematology, Western Galilee Hospital, Naharriya, Israel
  • 2The Bruce Rappaport Faculty of Medicine, The Technion, Haifa, Israel
  • 3Thrombosis Unit, National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel
  • 4Sackler Faculty of Medicine, University of Tel-Aviv, Tel-Aviv, Israel
  • 5Hemostasis Unit, Department of Hematology, Papageorgiou Hospital, Thessaloniki, Greece
  • 6Thrombosis and Hemostasis Unit, Institute of Hematology, Rambam Medical Center, Israel
Further Information

Publication History

Publication Date:
20 December 2011 (online)

   Permissions and Reprints
Preview

ABSTRACT

It has long been considered that a severe coagulation deficiency in premature newborns could be a major contributing factor in the occurrence of intraventricular hemorrhage (IVH). High-grade IVH has also been shown to coincide with severe derangement of coagulation in extremely low birth weight infants. This review focuses on the relevance of the physiologically developing immature hemostatic system to IVH, and the potential benefit of agents affecting hemostasis for IVH therapy or prevention in preterm infants. The findings of small, open-label interventional studies on the effect of ethamsylate, vitamin K, fresh frozen plasma, recombinant activated factor VII, and prothrombin complex concentrate on the premature coagulation system will be reviewed.

KEYWORDS

Intraventricular hemorrhage - prematurity - vitamin K - recombinant factor VIIa - thrombin

REFERENCES

  • 1 Fanaroff A A, Stoll B J, Wright L L NICHD Neonatal Research Network et al. Trends in neonatal morbidity and mortality for very low birthweight infants.  Am J Obstet Gynecol. 2007;  196 (2) 147, e1-e8
    Search in Google Scholar
  • 2 Vohr B R, Garcia-Coll C, Mayfield S, Brann B, Shaul P, Oh W. Neurologic and developmental status related to the evolution of visual-motor abnormalities from birth to 2 years of age in preterm infants with intraventricular hemorrhage.  J Pediatr. 1989;  115 (2) 296-302
    Search in Google Scholar
  • 3 Volpe J J. Neurology of the Newborn. 3rd ed. Philadelphia: Saunders; 1995
    Search in Google Scholar
  • 4 Hambleton G, Wigglesworth J S. Origin of intraventricular haemorrhage in the preterm infant.  Arch Dis Child. 1976;  51 (9) 651-659
    Search in Google Scholar
  • 5 Gould S J, Howard S. An immunohistochemical study of the germinal layer in the late gestation human fetal brain.  Neuropathol Appl Neurobiol. 1987;  13 (6) 421-437
    Search in Google Scholar
  • 6 Perlman J M, McMenamin J B, Volpe J J. Fluctuating cerebral blood-flow velocity in respiratory-distress syndrome. Relation to the development of intraventricular hemorrhage.  N Engl J Med. 1983;  309 (4) 204-209
    Search in Google Scholar
  • 7 Nakamura Y, Okudera T, Fukuda S, Hashimoto T. Germinal matrix hemorrhage of venous origin in preterm neonates.  Hum Pathol. 1990;  21 (10) 1059-1062
    Search in Google Scholar
  • 8 Reeder J D, Kaude J V, Setzer E S. Choroid plexus hemorrhage in premature neonates: recognition by sonography.  AJNR Am J Neuroradiol. 1982;  3 (6) 619-622
    Search in Google Scholar
  • 9 Papile L A, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.  J Pediatr. 1978;  92 (4) 529-534
    Search in Google Scholar
  • 10 Leviton A, Kuban K, Paneth N. Intraventricular haemorrhage grading scheme: time to abandon?.  Acta Paediatr. 2007;  96 (9) 1254-1256
    Search in Google Scholar
  • 11 Vasileiadis G T. Grading intraventricular hemorrhage with no grades.  Pediatrics. 2004;  113 (4) 930-931, author reply 930–931
    Search in Google Scholar
  • 12 Hope P L, Gould S J, Howard S, Hamilton P A, Costello A M, Reynolds E O. Precision of ultrasound diagnosis of pathologically verified lesions in the brains of very preterm infants.  Dev Med Child Neurol. 1988;  30 (4) 457-471
    Search in Google Scholar
  • 13 Amato M, Konrad D, Hüppi P, Donati F. Impact of prematurity and intrauterine growth retardation on neonatal hemorrhagic and ischemic brain damage.  Eur Neurol. 1993;  33 (4) 299-303
    Search in Google Scholar
  • 14 Linder N, Haskin O, Levit O et al.. Risk factors for intraventricular hemorrhage in very low birth weight premature infants: a retrospective case-control study.  Pediatrics. 2003;  111 (5 Pt 1) e590-e595
    Search in Google Scholar
  • 15 Lemons J A, Bauer C R, Oh W NICHD Neonatal Research Network et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996.  Pediatrics. 2001;  107 (1) E1
    Search in Google Scholar
  • 16 Horbar J D. Vermont-Oxford Network 1997 Database Summary. Burlington, VT: Vermont-Oxford Network; 1997
    Search in Google Scholar
  • 17 Levene M I, Fawer C L, Lamont R F. Risk factors in the development of intraventricular haemorrhage in the preterm neonate.  Arch Dis Child. 1982;  57 (6) 410-417
    Search in Google Scholar
  • 18 McCrea H J, Ment L R. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate.  Clin Perinatol. 2008;  35 (4) 777-792, vii
    Search in Google Scholar
  • 19 Whitelaw A. Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions.  Semin Neonatol. 2001;  6 (2) 135-146
    Search in Google Scholar
  • 20 Krishnamoorthy K S, Shannon D C, DeLong G R, Todres I D, Davis K R. Neurologic sequelae in the survivors of neonatal intraventricular hemorrhage.  Pediatrics. 1979;  64 (2) 233-237
    Search in Google Scholar
  • 21 Pinto-Martin J A, Whitaker A H, Feldman J F, Van Rossem R, Paneth N. Relation of cranial ultrasound abnormalities in low-birthweight infants to motor or cognitive performance at ages 2, 6, and 9 years.  Dev Med Child Neurol. 1999;  41 (12) 826-833
    Search in Google Scholar
  • 22 Vohr B, Garcia Coll C, Flanagan P, Oh W. Effects of intraventricular hemorrhage and socioeconomic status on perceptual, cognitive, and neurologic status of low birth weight infants at 5 years of age.  J Pediatr. 1992;  121 (2) 280-285
    Search in Google Scholar
  • 23 Vohr B R, Allan W C, Westerveld M et al.. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial.  Pediatrics. 2003;  111 (4 Pt 1) e340-e346
    Search in Google Scholar
  • 24 Ment L R, Bada H S, Barnes P D et al.. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.  Neurology. 2002;  58 (12) 1726-1738
    Search in Google Scholar
  • 25 Andrew M, Paes B, Milner R et al.. Development of the human coagulation system in the healthy premature infant.  Blood. 1988;  72 (5) 1651-1657
    Search in Google Scholar
  • 26 Andrew M, Paes B, Milner R et al.. Development of the human coagulation system in the full-term infant.  Blood. 1987;  70 (1) 165-172
    Search in Google Scholar
  • 27 Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus.  Blood. 1996;  88 (3) 900-906
    Search in Google Scholar
  • 28 Salonvaara M, Riikonen P, Kekomäki R et al.. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants.  Arch Dis Child Fetal Neonatal Ed. 2003;  88 (4) F319-F323
    Search in Google Scholar
  • 29 Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates.  J Thromb Haemost. 2003;  1 (2) 263-268
    Search in Google Scholar
  • 30 Cvirn G, Gallistl S, Kutschera J et al.. Clot strength: a comparison between cord and adult blood by means of thrombelastometry.  J Pediatr Hematol Oncol. 2008;  30 (3) 210-213
    Search in Google Scholar
  • 31 Kisker C T, Perlman S, Bohlken D, Wicklund B. Measurement of prothrombin mRNA during gestation and early neonatal development.  J Lab Clin Med. 1988;  112 (4) 407-412
    Search in Google Scholar
  • 32 Feusner J H, Slichter S J, Harker L A. Acquired haemostatic defects in the ill newborn.  Br J Haematol. 1983;  53 (1) 73-84
    Search in Google Scholar
  • 33 Schmidt B, Wais U, Pringsheim W, Kunzer W. Plasma elimination of antithrombin III is accelerated in term newborn infants.  Eur J Pediatr. 1984;  141 225-227
    Search in Google Scholar
  • 34 Corrigan Jr J J, Sleeth J J, Jeter M, Lox C D. Newborn's fibrinolytic mechanism: components and plasmin generation.  Am J Hematol. 1989;  32 (4) 273-278
    Search in Google Scholar
  • 35 Gray O P, Ackerman A, Fraser A J. Intracranial haemorrhage and clotting defects in low-birth-weight infants.  Lancet. 1968;  1 (7542) 545-548
    Search in Google Scholar
  • 36 Cade J F, Hirsh J, Martin M. Placental barrier to coagulation factors: its relevance to the coagulation defect at birth and to haemorrhage in the newborn.  BMJ. 1969;  2 (5652) 281-283
    Search in Google Scholar
  • 37 Piotrowski A, Dabrowska-Wojciak I, Mikinka M et al.. Coagulation abnormalities and severe intraventricular hemorrhage in extremely low birth weight infants.  J Matern Fetal Neonatal Med. 2010;  23 (7) 601-606
    Search in Google Scholar
  • 38 Fowlie P W, Davis P G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.  Cochrane Database Syst Rev. 2002;  (3) CD000174
    Search in Google Scholar
  • 39 Fowlie P W, Davis P G, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.  Cochrane Database Syst Rev. 2010;  (7) CD000174
    Search in Google Scholar
  • 40 Ment L R, Vohr B, Allan W et al.. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial.  Pediatrics. 2000;  105 (3 Pt 1) 485-491
    Search in Google Scholar
  • 41 Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants.  Eur J Pediatr. 2000;  159 (3) 153-155
    Search in Google Scholar
  • 42 Dani C, Bertini G, Pezzati M IntraVentricular Ibuprofen Study Group et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study.  Pediatrics. 2005;  115 (6) 1529-1535
    Search in Google Scholar
  • 43 Van Overmeire B, Allegaert K, Casaer A et al.. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial.  Lancet. 2004;  364 (9449) 1945-1949
    Search in Google Scholar
  • 44 Whitelaw A, Odd D. Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants.  Cochrane Database Syst Rev. 2007;  (4) CD001691
    Search in Google Scholar
  • 45 Chiswick M L, Johnson M, Woodhall C et al.. Protective effect of vitamin E (DL-alpha-tocopherol) against intraventricular haemorrhage in premature babies.  Br Med J (Clin Res Ed). 1983;  287 (6385) 81-84
    Search in Google Scholar
  • 46 Phelps D L, Rosenbaum A L, Isenberg S J, Leake R D, Dorey F J. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial.  Pediatrics. 1987;  79 (4) 489-500
    Search in Google Scholar
  • 47 Brion L P, Bell E F, Raghuveer T S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.  Cochrane Database Syst Rev. 2003;  (4) CD003665
    Search in Google Scholar
  • 48 Cools F, Offringa M. Neuromuscular paralysis for newborn infants receiving mechanical ventilation.  Cochrane Database Syst Rev. 2000;  (4) CD002773
    Search in Google Scholar
  • 49 Hunt R, Hey E. Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants.  Cochrane Database Syst Rev. 2010;  (1) CD004343
    Search in Google Scholar
  • 50 Hubbard D, Tobias J D. Intracerebral hemorrhage due to hemorrhagic disease of the newborn and failure to administer vitamin K at birth.  South Med J. 2006;  99 (11) 1216-1220
    Search in Google Scholar
  • 51 Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns.  Semin Perinatol. 1997;  21 (1) 70-85
    Search in Google Scholar
  • 52 Hey E. Vitamin K—what, why, and when.  Arch Dis Child Fetal Neonatal Ed. 2003;  88 (2) F80-F83
    Search in Google Scholar
  • 53 Clarke P, Mitchell S. Vitamin K prophylaxis in preterm infants: current practices.  J Thromb Haemost. 2003;  1 (2) 384-386
    Search in Google Scholar
  • 54 Costakos D T, Greer F R, Love L A, Dahlen L R, Suttie J W. Vitamin K prophylaxis for premature infants: 1 mg versus 0.5 mg.  Am J Perinatol. 2003;  20 (8) 485-490
    Search in Google Scholar
  • 55 Clarke P, Mitchell S J, Wynn R et al.. Vitamin K prophylaxis for preterm infants: a randomized, controlled trial of 3 regimens.  Pediatrics. 2006;  118 (6) e1657-e1666
    Search in Google Scholar
  • 56 American Academy of Pediatrics, Committee on Nutrition .Nutritional needs of preterm infants. In: Pediatric Nutrition Handbook. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2004: 350-351
    Search in Google Scholar
  • 57 Crowther C A, Crosby D D, Henderson-Smart D J. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage.  Cochrane Database Syst Rev. 2010;  (1) CD000229
    Search in Google Scholar
  • 58 Beverley D W, Pitts-Tucker T J, Congdon P J, Arthur R J, Tate G. Prevention of intraventricular haemorrhage by fresh frozen plasma.  Arch Dis Child. 1985;  60 (8) 710-713
    Search in Google Scholar
  • 59 Dani C, Poggi C, Ceciarini F, Bertini G, Pratesi S, Rubaltelli F F. Coagulopathy screening and early plasma treatment for the prevention of intraventricular hemorrhage in preterm infants.  Transfusion. 2009;  49 (12) 2637-2644
    Search in Google Scholar
  • 60 Veldman A, Josef J, Fischer D, Volk W R. A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life.  Pediatr Crit Care Med. 2006;  7 (1) 34-39
    Search in Google Scholar
  • 61 Waltl H, Födisch H J, Kurz R, Hohenauer L, Mitterstieler G, Rössler H. Intracranial haemorrhage in low-birth-weight infants and prophylactic administration of coagulation-factor concentrate.  Lancet. 1973;  1 (7815) 1284-1286
    Search in Google Scholar
  • 62 Thomas D B, Burnard E D. Prevention of intravascular haemorrhage in low-birthweight babies.  Lancet. 1973;  2 (7828) 562
    Search in Google Scholar
  • 63 Thomas D B, Burnard E D. Prevention of intraventricular haemorrhage in babies receiving artificial ventilation.  Med J Aust. 1973;  1 (19) 933-936
    Search in Google Scholar
  • 64 Gupta J M, Starr H, Fincher P, Lam-Po-Tang P R. Intraventricular haemorrhage in the newborn.  Med J Aust. 1976;  2 (9) 338-340
    Search in Google Scholar
  • 65 Turner T, Prowse C V, Prescott R J, Cash J D. A clinical trial on the early detection and correction of haemostatic defects in selected high-risk neonates.  Br J Haematol. 1981;  47 (1) 65-75
    Search in Google Scholar

Gili KenetM.D. 

Professor - Hematology, Thrombosis Unit, National Hemophilia Center

Sheba Medical Center, Tel Hashomer 52621, Israel

Email: Gili.kenet@sheba.health.gov.il